A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation.
View / Open Files
Authors
Giorgio, Joseph
Landau, Susan M
Tino, Peter
Alzheimer’s Disease Neuroimaging Initiative
Publication Date
2022-04-07Journal Title
Nat Commun
ISSN
2041-1723
Publisher
Nature Research
Type
Article
This Version
AM
Later Version(s)
Metadata
Show full item recordCitation
Giorgio, J., Jagust, W. J., Baker, S., Landau, S. M., Tino, P., Kourtzi, Z., & Alzheimer’s Disease Neuroimaging Initiative. (2022). A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation.. Nat Commun https://doi.org/10.1038/s41467-022-28795-7
Abstract
The early stages of Alzheimer's disease (AD) involve interactions between multiple pathophysiological processes. Although these processes are well studied, we still lack robust tools to predict individualised trajectories of disease progression. Here, we employ a robust and interpretable machine learning approach to combine multimodal biological data and predict future pathological tau accumulation. In particular, we use machine learning to quantify interactions between key pathological markers (β-amyloid, medial temporal lobe atrophy, tau and APOE 4) at mildly impaired and asymptomatic stages of AD. Using baseline non-tau markers we derive a prognostic index that: (a) stratifies patients based on future pathological tau accumulation, (b) predicts individualised regional future rate of tau accumulation, and (c) translates predictions from deep phenotyping patient cohorts to cognitively normal individuals. Our results propose a robust approach for fine scale stratification and prognostication with translation impact for clinical trial design targeting the earliest stages of AD.
Relationships
Is supplemented by: https://doi.org/10.17863/CAM.80891
Sponsorship
This work was supported by grants to: Z.K. from the Biotechnology and Biological Sciences Research Council (H012508 and BB/P021255/1), Alan Turing Institute (TU/B/000095), Wellcome Trust (205067/Z/16/Z, 221633/Z/20/Z), Royal Society (INF\R2\202107); Z.K. and W.J.J. from the Global Alliance; W.J.J. US National Institute on Aging (AG034570, AG062542,
AG024904). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012).
Funder references
Wellcome Trust (205067/Z/16/Z)
Biotechnology and Biological Sciences Research Council (BB/P021255/1)
Alan Turing Institute (EP/N510129/1)
Alan Turing Institute (SF\087)
Alan Turing Institute (Unknown)
Wellcome Trust (221633/Z/20/Z)
Alzheimer's Research UK (ARUK-EDoN2021-002)
Embargo Lift Date
2100-01-01
Identifiers
External DOI: https://doi.org/10.1038/s41467-022-28795-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/334023
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk